Vancomycin/tigecycline/polymyxin B is named as a drug or biological intervention in 2 clinical trials in our China trial register, none of which are currently recruiting. The lead sponsor is yilong Wang. Registered phase: Not applicable. Conditions studied include Blood-Brain Barrier; Bacterial Meningitis.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07495150 | Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis (ClinicalTrials.gov ↗) Blood-Brain Barrier, Bacterial Meningitis |
Not applicable | Not yet open |
| NCT07826351 | Exploring the Combination of Intracalvariosseous and Intravenous Antibiotics for Moderate to Severe Bacterial Meningitis (ClinicalTrials.gov ↗) Blood-Brain Barrier, Bacterial Meningitis |
Not applicable | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Blood-Brain Barrier | 2 |
| Bacterial Meningitis | 2 |
| Lead sponsor | Trials |
|---|---|
| yilong Wang | 2 |
| Register | Vancomycin/tigecycline/polymyxin B trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Vancomycin/tigecycline/polymyxin B works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Vancomycin/tigecycline/polymyxin B (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.